EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of Expression LncRNA‐xloc‐000303 , lncRNA‐LOC152578 and hsa‐miR‐29a in Patients Diagnosed With Colon Cancer in the Pre‐Treatment Stage

Elham Tahami iD, Abolfazl Akbari iD, Reza Nekouian iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Elham Tahami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Biomarkers, Tumor, Colonic Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Employing a panel of biomarkers may enable the early diagnosis of colorectal cancer. Among these biomarkers, long non‐coding RNAs (LncRNAs) and microRNAs (miRNAs) are significant due to their crucial roles in biological and metabolic processes.

Aims

Therefore, the objective of this research was to evaluate the diagnostic value of the biomarkers LncRNA‐xloc‐000303, lncRNA‐LOC152578, and miR‐29a in the pre‐treatment stage of colorectal cancer in Iranian patients. Materials and Methods In this study, 30 tumor tissue samples and 30 adjacent healthy tissue samples were collected, and RNA was extracted using the Trizol kit. Subsequently, the relative expression of the candidate microRNA and LncRNAs was analyzed using real‐time PCR. The obtained gene expression data were then analyzed using REST software.

Results

In this study, it was found that the expression of LncRNA‐xloc‐000303 in tumor tissues significantly increased compared to healthy tissue ( p < 0.001). Additionally, the analysis revealed that the expression level of lncRNA‐LOC152578 showed an increase in tumor tissues compared to healthy tissues ( p = 0.57), although these changes were not statistically significant. The results of the hsa‐miR‐29a expression analysis indicated a down regulation in tumor tissues compared to healthy tissues; however, this change was also not statistically significant ( p = 0.34).

Conclusion

The results indicated that the expression changes of LncRNA‐xloc‐000303 in cancer tissue were significant compared to adjacent healthy tissue, suggesting its potential use as a biomarker for diagnosing colorectal cancer. However, further studies are needed to evaluate the biomarker specificity of lncRNA‐LOC152578 and hsa‐miR‐29a. This study was conducted in an Iranian population and its results can be used in the future for personalized medicine in the prevention and treatment of colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRNA, Long NoncodingBiomarkers, TumorColonic NeoplasmsHumansFemaleMaleMiddle AgedGene Expression Regulation, NeoplasticIranAgedNeoplasm StagingEarly Detection of CancerCase-Control StudiesAdult

Stichwörter der Autor:innen

LncRNA‐xloc‐000303colorectal cancerlncRNA‐LOC152578miR‐29apre‐treatment stage

Substanzen

MicroRNAsRNA, Long NoncodingBiomarkers, TumorMIRN29a microRNA, human

Autor:innen und Institutionen

  • Department of Biotechnology, Iran University of Medical Sciences, Tehran, Iran.
  • Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
  • Mehresoheila Cancer Charity, Alborz, Iran.

ORCID-Profile: Elham Tahami, Abolfazl Akbari, Reza Nekouian

Förderung

  • Iran University of Medical Sciences

Zitieren

APA

Tahami, E., Akbari, A., & Nekouian, R. (2025). Assessment of Expression LncRNA‐xloc‐000303 , lncRNA‐LOC152578 and hsa‐miR‐29a in Patients Diagnosed With Colon Cancer in the Pre‐Treatment Stage. Cancer Reports. https://doi.org/10.1002/cnr2.70321

Vancouver

Tahami E, Akbari A, Nekouian R. Assessment of Expression LncRNA‐xloc‐000303 , lncRNA‐LOC152578 and hsa‐miR‐29a in Patients Diagnosed With Colon Cancer in the Pre‐Treatment Stage. Cancer Reports. 2025. doi:10.1002/cnr2.70321

BibTeX
@article{Tahami2025,
  author = {Tahami, Elham and Akbari, Abolfazl and Nekouian, Reza},
  title = {Assessment of Expression LncRNA‐xloc‐000303 , lncRNA‐LOC152578 and hsa‐miR‐29a in Patients Diagnosed With Colon Cancer in the Pre‐Treatment Stage},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70321}
}
Kostenlos starten →